| 영문 | intermittent positive pressure breathing(IPPB) | 한글 | 간헐적양압호흡 |
|---|---|---|---|
| 설명 | 폐를 팽창시키기 위하여 대기압보다 높은 압력을 이용하는 인공호흡법이다. 신생아 무기폐의 치료나 만성 폐쇄성 호흡기 질환의 급성 악화시, 진단을 위한 가래의 배출을 위하여, 또는 약제의 흡입에 사용하고 있다. 합병증으로 공기가슴증이나 심박출량의 감소가 올 수 있다. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| cat | catalysis, catalyst; cataract |
| CPTP | culture-positive toxin-positive |
| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
| CPAP | Continuous Positive Airway Pressure |
| auto-PEEP | Auto-positive end expiratory pressure |
|---|---|
| BiPAP | Bi-level positive airway pressure |
| BIPAP | Biphasic Positive Airway Pressure |
| CD34(+) | CD34 positive |
| CD4+ | CD4 positive |
| general acid-base catalysis | A catalytic reaction that involves the tranfer of a proton to or from anon-water molecule. (09 Oct 1997) |
|---|---|
| catalysis | <chemistry> The acceleration of a chemical reaction by a catalyst. (16 Mar 1998) |
| heterogeneous catalysis | <chemistry> A form of catalysis in which the catalyst is in different physical state than the reactants. (09 Jan 1998) |
| homogeneous catalysis | <chemistry> A form of catalysis in which the catalyst is in the same physical state than the reactants, for example reactants and catalyst are all gases. (09 Jan 1998) |
| CD4-positive T-lymphocytes | A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells. (12 Dec 1998) |
| CD8-positive T-lymphocytes | A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector). (12 Dec 1998) |
| gram-positive | <microbiology> Bacteria that retain the stain or that are resistant to decolourisation by alcohol during Gram's method of staining. This is a primary characteristic of bacteria whose cell wall is composed of a thick layer of peptidologlycan containing teichoic and lipoteichoic acid complexed to the peptidoglycan. See: gram-negative (06 Oct 1997) |
| gram-positive asporogenous rods | <microbiology> A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common. (12 Dec 1998) |
| gram-positive asporogenous rods, irregular | <microbiology> A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores. (12 Dec 1998) |
| gram-positive asporogenous rods, regular | <microbiology> A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores. (12 Dec 1998) |
| gram-positive bacteria | <microbiology> Bacteria which retain the crystal violet stain when treated by gram's method. (12 Dec 1998) |
| gram-positive bacterial infections | <microbiology> Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. (12 Dec 1998) |
| gram-positive cocci | <microbiology> Coccus-shaped bacteria that retain the crystal violet stain when treated by gram's method. (12 Dec 1998) |
| gram-positive endospore-forming bacteria | <microbiology> Bacteria that form endospores and are gram-positive. Representative genera include bacillus, clostridium, micromonospora, saccharopolyspora, and streptomyces. (12 Dec 1998) |
| gram-positive endospore-forming rods | <microbiology> Rod-shaped bacteria that form endospores and are gram-positive. Representative genera include bacillus and clostridium. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|